• N/A
    Market Cap
  • -98.98%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
03/31/2026
03/31/2025
03/31/2024
03/31/2023
Income Statement
Total Operating Revenue
1.1M
-34.63%
1.7M
-9.73%
1.9M
-2.19%
2.0M
-24.23%
Cost of Revenue
889,350
-35.25%
1.4M
-0.08%
1.4M
-11.06%
1.5M
+14.42%
Gross Profit
248,702
-32.31%
367,427
-33.67%
553,971
+29.96%
426,271
-65.94%
Sales and Marketing Expense
244,185
-15.76%
289,859
-33.15%
433,566
+11.90%
387,452
-58.09%
Research and Development Expense
N/A
N/A
N/A
N/A
-184,194
N/A
N/A
N/A
Depreciation and Amortization Expense
73,668
-10.49%
82,297
-59.51%
203,247
-18.75%
250,162
-21.83%
Total Operating Expenses
7.4M
+141.86%
3.0M
-0.69%
3.1M
-49.13%
6.0M
-6.33%
Operating Profit
-7.1M
+165.73%
-2.7M
+6.57%
-2.5M
-55.15%
-5.6M
+8.05%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-19,586
0.00%
-19,586
N/A
N/A
N/A
-476,776
+1,199.29%
Interest Income and Expense and Net
-19,586
0.00%
-19,586
N/A
0
+100.00%
-476,776
+1,199.29%
Total Nonoperating Income and Expense
917,848
+247.29%
-623,173
+6.83%
-583,315
+78.24%
-327,263
+49.93%
Income before Taxes
-6.2M
+87.83%
-3.3M
+6.62%
-3.1M
-47.79%
-5.9M
+9.74%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
401,995
+15.06%
349,390
N/A
Net Income
-5.3M
+61.26%
-3.3M
+6.62%
-3.1M
-47.79%
-5.9M
+3.46%
Net Income from Continuing Operations Applicable to Common
-6.2M
+87.83%
-3.3M
+6.62%
-3.1M
-47.79%
-5.9M
+9.74%
Basic EPS and Net Income
-9.13
+293.36%
-2.32
-35.02%
-3.57
+301.80%
-0.89
-116.11%
Diluted EPS and Net Income
-9.13
+293.36%
-2.32
-35.02%
-3.57
+301.80%
-0.89
-116.11%
Basic Weighted Average Shares
679,648
-52.25%
1.4M
+64.08%
867,422
-87.00%
6.7M
+541.91%
Diluted Weighted Average Shares
679,648
-52.25%
1.4M
+64.08%
867,422
-87.00%
6.7M
+541.91%
Balance Sheet
Cash and Cash Equivalents
28.2M
+55.68%
18.1M
+49.95%
12.1M
-30.50%
17.4M
+11.88%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
28.2M
+55.68%
18.1M
+49.95%
12.1M
-30.50%
17.4M
+11.88%
Total Current Assets
34.5M
+62.04%
21.3M
+49.62%
14.2M
-27.09%
19.5M
-13.05%
Accumulated Depreciation
2.2M
+8.69%
2.0M
+0.21%
2.0M
+5.22%
1.9M
+5.58%
Property and Plant and Equipment and Net
117,103
-34.42%
178,561
-45.70%
328,845
-65.82%
962,214
-21.63%
Total Long-Term Assets
244,852
-33.29%
367,017
-95.87%
8.9M
-11.35%
10.0M
-9.57%
Total Assets
34.8M
+60.43%
21.7M
-6.33%
23.1M
-21.75%
29.6M
-11.90%
Income Taxes Payable
2,871
-99.72%
1.0M
-2.00%
1.1M
-4.74%
1.1M
-5.38%
Total Short-Term Debt
6.9M
+869.81%
710,965
+38.22%
514,383
+193.40%
175,316
-98.37%
Total Current Liabilities
4.3M
-27.66%
6.0M
-32.46%
8.9M
-38.59%
14.5M
-15.33%
Total Long-Term Debt
19,586
-79.65%
96,264
-17.81%
117,129
-0.62%
117,862
N/A
Total Long-Term Liabilities
697,832
+229.66%
211,683
-28.16%
294,667
-19.45%
365,823
N/A
Total Liabilities
5.0M
-18.90%
6.2M
-32.33%
9.2M
-38.12%
14.9M
-13.19%
Retained Earnings
-34.2M
+22.15%
-28.0M
+13.37%
-24.7M
+14.34%
-21.6M
+37.77%
Total Stockholders Equity
29.7M
+92.41%
15.4M
+10.83%
13.9M
-5.18%
14.7M
-10.55%
Total Shares Outstanding
958,077
-93.04%
13.8M
+520.47%
2.2M
-80.60%
11.4M
+462.87%
Cash Flow
Cash from Operating Activities
-4.0M
+71.30%
-2.3M
+21.64%
-1.9M
+2,287.47%
-80,757
-130.10%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-1.3M
-2,069.46%
63,516
+140.38%
26,423
+314.77%
-12,303
-73.77%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
14.4M
+71.84%
8.4M
+420.04%
-2.6M
-189.22%
2.9M
+84.41%
Financials Ratio
Gross Margin
21.85%
+3.54%
21.11%
-26.53%
28.73%
+32.87%
21.62%
-55.05%
Operating Margin
-625.89%
+306.50%
-153.97%
+18.05%
-130.42%
-54.14%
-284.40%
+42.61%
Return on Assets
-18.89%
+28.02%
-14.75%
+25.40%
-11.76%
-37.46%
-18.81%
+11.65%
Return on Equity
-23.60%
+4.91%
-22.50%
+3.90%
-21.65%
-43.24%
-38.15%
+7.69%
Revenue Growth
-34.63%
+256.00%
-9.73%
+344.15%
-2.19%
-90.96%
-24.23%
-46.78%
Current Ratio
7.93
+123.99%
3.54
+121.55%
1.60
+18.74%
1.35
+2.69%
Cash Ratio
6.48
+115.19%
3.01
+122.03%
1.36
+13.17%
1.20
+32.14%
Debt-to-Equity Ratio
0.23
+345.12%
0.05
+15.45%
0.05
+126.50%
0.02
N/A
Debt-to-Assets Ratio
0.20
+433.51%
0.04
+36.63%
0.03
+175.76%
0.010
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow